Moliterno AR - Search Results

1

Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.

Upreti H, Kasmani J, Dane K, Braunstein EM, Streiff MB, Shanbhag S, Moliterno AR, Sperati CJ, Gottesman RF, Brodsky RA, Kickler TS, Chaturvedi S. Upreti H, et al. Among authors: moliterno ar. Blood. 2019 Sep 26;134(13):1037-1045. doi: 10.1182/blood.2019001056. Epub 2019 Aug 20. Blood. 2019. PMID: 31431443 Free PMC article.

2

Acute cardiomyopathy in a patient with thrombotic thrombocytopenic purpura.

Zhan H, Zheng H, Moliterno AR, Streiff MB. Zhan H, et al. Among authors: moliterno ar. Am J Med. 2010 Feb;123(2):e3-4. doi: 10.1016/j.amjmed.2009.07.021. Am J Med. 2010. PMID: 20103008 No abstract available.

3

Back to biology: new insights on inheritance in myeloproliferative disorders.

Braunstein EM, Moliterno AR. Braunstein EM, et al. Among authors: moliterno ar. Curr Hematol Malig Rep. 2014 Dec;9(4):311-8. doi: 10.1007/s11899-014-0232-3. Curr Hematol Malig Rep. 2014. PMID: 25195195 Free PMC article. Review.

4

Modified Ham test for atypical hemolytic uremic syndrome.

Gavriilaki E, Yuan X, Ye Z, Ambinder AJ, Shanbhag SP, Streiff MB, Kickler TS, Moliterno AR, Sperati CJ, Brodsky RA. Gavriilaki E, et al. Among authors: moliterno ar. Blood. 2015 Jun 4;125(23):3637-46. doi: 10.1182/blood-2015-02-629683. Epub 2015 Apr 10. Blood. 2015. PMID: 25862562 Free PMC article. Clinical Trial.

5

Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.

Sperati CJ, Moliterno AR. Sperati CJ, et al. Among authors: moliterno ar. Hematol Oncol Clin North Am. 2015 Jun;29(3):541-59. doi: 10.1016/j.hoc.2015.02.002. Epub 2015 Apr 4. Hematol Oncol Clin North Am. 2015. PMID: 26043391 Review.

6

Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post-JAK2 V617F Discovery Era.

Kander EM, Moliterno AR, Rademaker A, Streiff MB, Spivak JL, Stein BL. Kander EM, et al. Among authors: moliterno ar. J Natl Compr Canc Netw. 2016 Oct;14(10):1238-1245. doi: 10.6004/jnccn.2016.0133. J Natl Compr Canc Netw. 2016. PMID: 27697978

7

Eculizumab cessation in atypical hemolytic uremic syndrome.

Merrill SA, Brittingham ZD, Yuan X, Moliterno AR, Sperati CJ, Brodsky RA. Merrill SA, et al. Among authors: moliterno ar. Blood. 2017 Jul 20;130(3):368-372. doi: 10.1182/blood-2017-02-770214. Epub 2017 May 1. Blood. 2017. PMID: 28461395 Free PMC article.

8

Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention.

Dane KE, Lindsley JP, Streiff MB, Moliterno AR, Khalid MK, Shanbhag S. Dane KE, et al. Among authors: moliterno ar. Res Pract Thromb Haemost. 2019 Apr 9;3(3):420-423. doi: 10.1002/rth2.12201. eCollection 2019 Jul. Res Pract Thromb Haemost. 2019. PMID: 31294330 Free PMC article.

9

Inflammation exerts a nonrandom risk in the acquisition and progression of the MPN: Insights from a Mendelian randomization study.

Karantanos T, Kaizer H, Chaturvedi S, Resar LMS, Moliterno AR. Karantanos T, et al. Among authors: moliterno ar. EClinicalMedicine. 2020 Apr 18;21:100324. doi: 10.1016/j.eclinm.2020.100324. eCollection 2020 Apr. EClinicalMedicine. 2020. PMID: 32322810 Free PMC article. No abstract available.

10

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden.

Karantanos T, Chaturvedi S, Braunstein EM, Spivak J, Resar L, Karanika S, Williams DM, Rogers O, Gocke CD, Moliterno AR. Karantanos T, et al. Among authors: moliterno ar. Blood Adv. 2020 Jun 23;4(12):2567-2576. doi: 10.1182/bloodadvances.2019001407. Blood Adv. 2020. PMID: 32542392 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page